Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chitra Hosing

Showing results (81-90 of 234) with videos related to

Pageof 24
Sort By:
Advances in Hematology|November 24, 2011
Steroid-Refractory Acute GVHD: Predictors and OutcomesJason R Westin, Rima M Saliba, Marcos De Lima, et al.
Blood|April 8, 2004
Tumor necrosis factor-alpha blockade for the treatment of acute GVHDDaniel Couriel, Rima Saliba, Krystal Hicks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United StatesChitra Hosing, Richard Nash, Peter McSweeney, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib eraRichard Champlin, Marcos de Lima, Partow Kebriaei, et al.
American Journal of Hematology|April 23, 2009
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphomaChitra Hosing, Rima M Saliba, Sheena Ahlawat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignanciesPartow Kebriaei, Timothy Madden, Reza Kazerooni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantationDaniel R Couriel, Rima M Saliba, Sergio Giralt, et al.
Pageof 24

Showing results (81-90 of 234) with videos related to

Sort By:
Pageof 24
Advances in Hematology|November 24, 2011
Steroid-Refractory Acute GVHD: Predictors and OutcomesJason R Westin, Rima M Saliba, Marcos De Lima, et al.
Blood|April 8, 2004
Tumor necrosis factor-alpha blockade for the treatment of acute GVHDDaniel Couriel, Rima Saliba, Krystal Hicks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United StatesChitra Hosing, Richard Nash, Peter McSweeney, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib eraRichard Champlin, Marcos de Lima, Partow Kebriaei, et al.
American Journal of Hematology|April 23, 2009
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphomaChitra Hosing, Rima M Saliba, Sheena Ahlawat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignanciesPartow Kebriaei, Timothy Madden, Reza Kazerooni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantationDaniel R Couriel, Rima M Saliba, Sergio Giralt, et al.
Pageof 24